Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery.
Kono M, Kumai T, Hayashi R, Yamaki H, Komatsuda H, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Kobayashi H, Harabuchi Y. Kono M, et al. Among authors: wakisaka r. Cancer Immunol Immunother. 2021 Dec;70(12):3421-3434. doi: 10.1007/s00262-021-02940-5. Epub 2021 Apr 18. Cancer Immunol Immunother. 2021. PMID: 33866408 Free PMC article.
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Kobayashi H, Harabuchi Y. Kono M, et al. Among authors: wakisaka r. Oncoimmunology. 2022 Jan 3;11(1):2021619. doi: 10.1080/2162402X.2021.2021619. eCollection 2022. Oncoimmunology. 2022. PMID: 35003900 Free PMC article.
Antitumor Peptide-Based Vaccine in the Limelight.
Kumai T, Yamaki H, Kono M, Hayashi R, Wakisaka R, Komatsuda H. Kumai T, et al. Among authors: wakisaka r. Vaccines (Basel). 2022 Jan 3;10(1):70. doi: 10.3390/vaccines10010070. Vaccines (Basel). 2022. PMID: 35062731 Free PMC article. Review.
Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous fistula: A case report and retrospective analysis of 12 cases.
Ohara K, Katada A, Kumai T, Ominato H, Hirata-Nozaki Y, Sabusawa T, Yamaki H, Kono M, Komatsuda H, Wakisaka R, Takahara M, Hayashi T, Harabuchi Y. Ohara K, et al. Among authors: wakisaka r. Auris Nasus Larynx. 2023 Aug;50(4):628-631. doi: 10.1016/j.anl.2022.04.011. Epub 2022 May 12. Auris Nasus Larynx. 2023. PMID: 35568581 Free article.
Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer.
Wakisaka R, Yamaki H, Kono M, Inoue T, Sato R, Komatsuda H, Ohara K, Kosaka A, Ohkuri T, Nagato T, Kishibe K, Nakayama K, Kobayashi H, Kumai T, Takahara M. Wakisaka R, et al. Cancers (Basel). 2024 Aug 29;16(17):3013. doi: 10.3390/cancers16173013. Cancers (Basel). 2024. PMID: 39272872 Free PMC article.
25 results